A new database targeting chronic urinary tract infections (UTIs)—a long-overlooked condition that may begin in childhood—is set to help researchers uncover why millions of women and girls worldwide ...

The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

Ed O'Keefe is CBS News' senior White House and political correspondent reporting for all CBS News platforms. He's part of the team covering President Trump and covered all four years of Joe Biden's ...

Genetics play a role in low testosterone for some men, but underlying causes vary widely. Many genes influence testosterone ...

Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in prostate cancer risk. About 1 in ...

Genetic screening for prostate cancer can help identify inherited risks early, guide treatment decisions, and protect your family’s health. At Fred Hutch Cancer Center, we offer expert genetic ...

1 Department of Urology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China 2 Department of Urology, The Second Hospital of Longyan, Longyan, Fujian, China Background: The prognostic ...

New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and ...

This figure shows the structure of PTGES3. The research team made the association after creating a fluorescent tag that tracks androgen receptor levels in real time. The androgen receptor is a hormone ...

IOWA CITY, Iowa (KWQC) -Prostate cancer remains the most common non-skin cancer in men and the second deadliest after lung cancer, according to the American Association of Cancer Research. As part of ...

The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...